CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR‐33a/b to disinhibit PD‐L1

Diffuse large B‐cell lymphoma (DLBCL) is the most common lymphoid malignancy with a high relapse rate of up to 40%. The prognosis of the disease needs improvement and requires a understanding of its molecular mechanism. We investigated the mechanisms of DLBCL development and its sensitivity to chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Lihua, Huang, Jingjing, Gao, Xue, Du, Jianwei, Wang, Yesheng, Zhao, Lingdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357607/
https://www.ncbi.nlm.nih.gov/pubmed/35579082
http://dx.doi.org/10.1111/cas.15402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357607/
https://www.ncbi.nlm.nih.gov/pubmed/35579082
http://dx.doi.org/10.1111/cas.15402

Ejemplares similares